Gemcitabine plus cisplatin (GCis) versus gemcitabine plus carboplatin (GCarb) in patients wiht stage IIIB and IV non-small-cell lung cancer (NSCLC): final result of Czech Lung Cancer Cooperative Group phase III randomized trial